醫療設備產業:競爭格局
市場調查報告書
商品編碼
1601591

醫療設備產業:競爭格局

Medical Devices Industry: Competitive Landscape

出版日期: | 出版商: BCC Research | 英文 213 Pages | 訂單完成後即時交付

價格

全球醫療設備市場規模預計將從 2024 年的 8,104 億美元增至 2029 年的 1.3 兆美元,預測期內複合年成長率為 9.8%。

北美市場預計將從2024年的4,266億美元成長到2029年的6,973億美元,複合年成長率為10.3%。亞太市場預計到2029年將達到2,269億美元,複合年成長率為12.4%,較2024年的1,266億美元成長12.4%。

本報告調查了全球醫療設備產業的競爭格局,並提供了市場概況、市場影響因素和市場機會分析、法律制度、新興技術和技術發展趨勢、市場規模趨勢和預測以及區域細分。分析、競爭格局、主要企業簡介等。

目錄

第1章執行摘要

  • 市場展望
  • 調查範圍
  • 市場概況

第2章 市場概況

  • 概述
  • 醫療設備代碼
  • 影像系統
  • 體外診斷
  • 心血管疾病的治療
  • 整形外科和脊椎外科
  • 醫療設備創新
  • 相關利益者參與創新過程
  • PESTEL分析
  • 波特五力分析
  • 供應鏈分析

第3章市場動態

  • 市場動態
  • 市場促進因素
  • 技術進步
  • 醫療費用增加
  • 手術次數增加
  • 慢性病增加和人口老化
  • 市場限制因素
  • 對嚴格監管的擔憂
  • 市場機會
  • 改善新興經濟體的衛生基礎設施
  • 市場挑戰
  • 醫療設備業的網路安全風險

第4章 監管狀況

  • 法律規範
  • 美國
  • 歐洲聯盟
  • 日本
  • 其他亞洲地區

第5章新興技術與發展

  • 新興技術
  • 區塊鏈資料安全
  • 奈米科技
  • 智慧/創新植入
  • 專利分析

第6章醫療設備業的永續性:ESG 視角

  • 醫療設備業的永續性
  • 了解 ESG資料
  • 環境績效
  • 社會表現
  • 管治績效
  • BCC的結語

第7章 競爭訊息

  • 概述
  • 主要醫療設備廠商策略
  • 分銷網路

第8章附錄

  • 調查方法
  • 簡稱
  • 來源
  • 公司簡介
  • ABBOTT
  • ALCON INC.
  • ALIGN TECHNOLOGY INC.
  • B. BRAUN SE
  • BAXTER
  • BD
  • BIO-RAD LABORATORIES INC.
  • BOSTON SCIENTIFIC CORP.
  • BRUKER
  • CARDINAL HEALTH
  • COCHLEAR LTD.
  • DANAHER CORP.
  • DEXCOM INC.
  • DENTSPLY SIRONA
  • DRAGERWERK AG & CO. KGAA
  • F. HOFFMANN-LA ROCHE LTD.
  • GE HEALTHCARE
  • GERRESHEIMER AG
  • INTUITIVE SURGICAL
  • JOHNSON & JOHNSON SERVICES INC.
  • KONINKLIJKE PHILIPS NV
  • LIVANOVA PLC.
  • MEDTRONIC
  • SIEMENS HEALTHINEERS AG
  • SMITH & NEPHEW PLC
  • STRYKER
  • SYSMEX CORP.
  • TERUMO CORP.
  • WUXI APPTEC
  • YPSOMED
  • ZEISS AG
  • ZIMMER BIOMET
Product Code: MDS010C

The global market for medical devices is estimated to increase from 810.4 billion in 2024 to reach $1.3 trillion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.

The North American market for medical devices is estimated to increase from $426.6 billion in 2024 to reach $697.3 billion by 2029, at a CAGR of 10.3% from 2024 through 2029.

The Asia-Pacific market for medical devices is estimated to increase from $126.6 billion in 2024 to reach $226.9 billion by 2029, at a CAGR of 12.4% from 2024 through 2029.

Report Scope:

This research report provides an in-depth analysis of the global medical device market and its competitive landscape through 2023. The report covers key players, competitive intelligence, advanced technologies and company profiles. The analysis includes recent developments and product portfolios of major players, as well as market share analysis and ranking. The analysis of the regulatory landscape focuses on recent regulations in regions such as the U.S., Europe and Japan. BCC Research estimates market size data for 2023 (base year) and forecasts values for 2024 through the end of 2029. This report also examines growth trends, drivers, restraints and opportunities in the global medical device market.

Report Includes:

  • 33 data tables and 111 additional tables
  • Analysis of global market trends, with market revenue data from 2021 to 2023, estimates for 2024, and projected CAGRs through 2029
  • Discussion of the market potential and opportunities in the medical device industry, along with an analysis of the competitive environment, regulatory scenario, and technological advances
  • Facts and figures pertaining to R&D activity, technology issues, industry-specific challenges, and the impact of macroeconomic factors
  • A look at the regulatory and pricing scenarios in the global market, with an emphasis on recent regulations in the U.S., Europe and Japan
  • Analysis of the industry structure, including companies' market shares and rankings, strategic alliances, M&A activity and a venture funding outlook
  • Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, and the ESG scores and practices of leading companies
  • Patent activity and key granted and published patents
  • Company profiles of major players within the industry, including Medtronic, Abbott, Johnson & Johnson, Siemens Healthineers AG, and F. Hoffmann-La Roche Ltd.

Table of Contents

Chapter 1 Executive Summary

  • Market Outlook
  • Scope of Report
  • Market Summary

Chapter 2 Market Overview

  • Overview
  • Medical Device Codes
  • Imaging Systems
  • In Vitro Diagnostics
  • Cardiovascular Disease Procedures
  • Orthopedic and Spinal Procedures
  • Innovations in Medical Devices
  • Stakeholders Involved in the Innovation Process
  • PESTEL Analysis
  • Porter's Five Forces Analysis
  • Supply Chain Analysis
  • Raw Materials Sourcing
  • Manufacturing
  • Packaging and Sterilization
  • Regulatory Approval
  • Distribution
  • Aftermarket Services and Support
  • Disposal

Chapter 3 Market Dynamics

  • Market Dynamics
  • Market Drivers
  • Technological Advances
  • Rising Healthcare Expenditures
  • Growing Numbers of Surgical Procedures
  • Increasing Prevalence of Chronic Diseases and Aging Population
  • Market Restraints
  • Stringent Regulatory Concerns
  • Market Opportunities
  • Improving Healthcare Infrastructure in Developing Economies
  • Market Challenges
  • Cybersecurity Risks in the Medical Device Industry

Chapter 4 Regulatory Landscape

  • Regulatory Framework
  • U.S.
  • European Union
  • Japan
  • Rest of Asia

Chapter 5 Emerging Technologies and Developments

  • Emerging Technologies
  • Blockchain for Data Security
  • Nanotechnology
  • Smart/Innovative Implants
  • Patent Analysis

Chapter 6 Sustainability in the Medical Devices Industry: An ESG Perspective

  • Sustainability in the Medical Device Industry
  • Understanding the ESG Data
  • Environmental Performance
  • Social Performance
  • Governance Performance
  • Concluding Remarks from BCC

Chapter 7 Competitive Intelligence

  • Overview
  • Strategies of Major Medical Device Manufacturers
  • Distribution Networks

Chapter 8 Appendix

  • Methodology
  • Abbreviations
  • Sources
  • Company Profiles
  • ABBOTT
  • ALCON INC.
  • ALIGN TECHNOLOGY INC.
  • B. BRAUN SE
  • BAXTER
  • BD
  • BIO-RAD LABORATORIES INC.
  • BOSTON SCIENTIFIC CORP.
  • BRUKER
  • CARDINAL HEALTH
  • COCHLEAR LTD.
  • DANAHER CORP.
  • DEXCOM INC.
  • DENTSPLY SIRONA
  • DRAGERWERK AG & CO. KGAA
  • F. HOFFMANN-LA ROCHE LTD.
  • GE HEALTHCARE
  • GERRESHEIMER AG
  • INTUITIVE SURGICAL
  • JOHNSON & JOHNSON SERVICES INC.
  • KONINKLIJKE PHILIPS N.V.
  • LIVANOVA PLC.
  • MEDTRONIC
  • SIEMENS HEALTHINEERS AG
  • SMITH & NEPHEW PLC
  • STRYKER
  • SYSMEX CORP.
  • TERUMO CORP.
  • WUXI APPTEC
  • YPSOMED
  • ZEISS AG
  • ZIMMER BIOMET

List of Tables

  • Summary Table : Global Market for Medical Devices, by Region, Through 2029
  • Table 1 : Medical Device Codes
  • Table 2 : Global Health Expenditures, by Country, 2022
  • Table 3 : Global Incidence of All Cancers, by WHO Region, 2022-2050
  • Table 4 : Elderly Population, by Country, 2021 and 2022
  • Table 5 : Regulatory Approval: U.S. vs. Europe
  • Table 6 : Regulatory Framework in the Global Medical Device Market
  • Table 7 : Medical Device Technology Patents Granted, by Assignee Company, 2023
  • Table 8 : Medical Device Technology Patents Granted, by Assignee Country, 2023
  • Table 9 : ESG Rankings for Major Medical Device Companies, 2024*
  • Table 10 : ESG: Environmental Performance in the Medical Device Industry
  • Table 11 : ESG: Social Factors Performance in the Medical Device Industry
  • Table 12 : ESG: Governance Performance in the Medical Device Industry
  • Table 13 : Market Shares of Leading Medical Device Companies, 2023
  • Table 14 : Abbreviations Used in this Report
  • Table 15 : Information Sources Used for this Report
  • Table 16 : Abbott: Company Snapshot
  • Table 17 : Abbott: Financial Performance, FY 2022 and 2023
  • Table 18 : Abbott: Product Portfolio
  • Table 19 : Abbott: News/Key Developments, 2022-2024
  • Table 20 : Alcon Inc.: Company Snapshot
  • Table 21 : Alcon Inc.: Financial Performance, FY 2022 and 2023
  • Table 22 : Alcon Inc.: Product Portfolio
  • Table 23 : Alcon Inc.: News/Key Developments, 2022-2024
  • Table 24 : Align Technology Inc.: Company Snapshot
  • Table 25 : Align Technology Inc.: Financial Performance, FY 2022 and 2023
  • Table 26 : Align Technology Inc.: Product Portfolio
  • Table 27 : Align Technology Inc.: News/Key Developments, 2022-2024
  • Table 28 : B. Braun SE: Company Snapshot
  • Table 29 : B. Braun SE: Financial Performance, FY 2022 and 2023
  • Table 30 : B. Braun SE: Product Portfolio
  • Table 31 : B. Braun SE: News/Key Developments, 2022-2024
  • Table 32 : Baxter: Company Snapshot
  • Table 33 : Baxter: Financial Performance, FY 2022 and 2023
  • Table 34 : Baxter: Product Portfolio
  • Table 35 : Baxter: News/Key Developments, 2022-2024
  • Table 36 : BD: Company Snapshot
  • Table 37 : BD: Financial Performance, FY 2022 and 2023
  • Table 38 : BD: Product Portfolio
  • Table 39 : BD: News/Key Developments, 2022-2024
  • Table 40 : Bio-Rad Laboratories Inc.: Company Snapshot
  • Table 41 : Bio-Rad Laboratories Inc.: Financial Performance, FY 2022 and 2023
  • Table 42 : Bio-Rad Laboratories Inc.: Product Portfolio
  • Table 43 : Bio-Rad Laboratories Inc.: News/Key Developments, 2022-2024
  • Table 44 : Boston Scientific Corp.: Company Snapshot
  • Table 45 : Boston Scientific Corp.: Financial Performance, FY 2022 and 2023
  • Table 46 : Boston Scientific Corp.: Product Portfolio
  • Table 47 : Boston Scientific Corp.: News/Key Developments, 2022-2024
  • Table 48 : Bruker: Company Snapshot
  • Table 49 : Bruker: Financial Performance, FY 2022 and 2023
  • Table 50 : Bruker: Product Portfolio
  • Table 51 : Bruker: News/Key Developments, 2022-2024
  • Table 52 : Cardinal Health: Company Snapshot
  • Table 53 : Cardinal Health: Financial Performance, FY 2022 and 2023
  • Table 54 : Cardinal Health: Product Portfolio
  • Table 55 : Cardinal Health: News/Key Developments, 2022-2024
  • Table 56 : Cochlear Ltd.: Company Snapshot
  • Table 57 : Cochlear Ltd.: Financial Performance, FY 2022 and 2023
  • Table 58 : Cochlear Ltd.: Product Portfolio
  • Table 59 : Cochlear Ltd.: News/Key Developments, 2022-2024
  • Table 60 : Danaher Corp.: Company Snapshot
  • Table 61 : Danaher Corp.: Financial Performance, FY 2022 and 2023
  • Table 62 : Danaher Corp.: Product Portfolio
  • Table 63 : Danaher Corp.: News/Key Developments, 2022-2024
  • Table 64 : Dexcom Inc.: Company Snapshot
  • Table 65 : Dexcom Inc.: Financial Performance, FY 2022 and 2023
  • Table 66 : Dexcom Inc.: Product Portfolio
  • Table 67 : Dexcom Inc.: News/Key Developments, 2022-2024
  • Table 68 : Dentsply Sirona: Company Snapshot
  • Table 69 : Dentsply Sirona: Financial Performance, FY 2022 and 2023
  • Table 70 : Dentsply Sirona: Product Portfolio
  • Table 71 : Dentsply Sirona: News/Key Developments, 2022-2024
  • Table 72 : Dragerwerk AG & Co. KGaA: Company Snapshot
  • Table 73 : Dragerwerk AG & Co. KGaA: Financial Performance, FY 2022 and 2023
  • Table 74 : Dragerwerk AG & Co. KGaA: Product Portfolio
  • Table 75 : Dragerwerk AG & Co. KGaA: News/Key Developments, 2024
  • Table 76 : F. Hoffmann-La Roche Ltd.: Company Snapshot
  • Table 77 : F. Hoffmann-La Roche Ltd.: Financials, FY 2022 and 2023
  • Table 78 : F. Hoffmann-La Roche Ltd.: Product Portfolio
  • Table 79 : F. Hoffmann-La Roche Ltd.: News/Key Developments, 2022-2024
  • Table 80 : GE HealthCare: Company Snapshot
  • Table 81 : GE HealthCare: Financial Performance, FY 2022 and 2023
  • Table 82 : GE HealthCare: Product Portfolio
  • Table 83 : GE HealthCare: News/Key Developments, 2022-2024
  • Table 84 : Gerresheimer AG: Company Snapshot
  • Table 85 : Gerresheimer AG: Financial Performance, FY 2022 and 2023
  • Table 86 : Gerresheimer AG: Product Portfolio
  • Table 87 : Gerresheimer AG: News/Key Developments, 2022-2024
  • Table 88 : Intuitive Surgical: Company Snapshot
  • Table 89 : Intuitive Surgical: Financial Performance, FY 2022 and 2023
  • Table 90 : Intuitive Surgical: Product Portfolio
  • Table 91 : Intuitive Surgical: News/Key Developments, 2022-2024
  • Table 92 : Johnson & Johnson Services Inc.: Company Snapshot
  • Table 93 : Johnson & Johnson Services Inc.: Financial Performance, FY 2022 and 2023
  • Table 94 : Johnson & Johnson Services Inc.: Product Portfolio
  • Table 95 : Johnson & Johnson Services Inc.: News/Key Developments, 2022-2024
  • Table 96 : Koninklijke Philips N.V.: Company Snapshot
  • Table 97 : Koninklijke Philips N.V.: Financial Performance, FY 2022 and 2023
  • Table 98 : Koninklijke Philips N.V.: Product Portfolio
  • Table 99 : Koninklijke Philips N.V.: News/Key Developments, 2022-2024
  • Table 100 : LivaNova PLC.: Company Snapshot
  • Table 101 : LivaNova PLC.: Financial Performance, FY 2022 and 2023
  • Table 102 : LivaNova PLC.: Product Portfolio
  • Table 103 : Medtronic: Company Snapshot
  • Table 104 : Medtronic: Financial Performance, FY 2022 and 2023
  • Table 105 : Medtronic: Product Portfolio
  • Table 106 : Medtronic: Patient Monitoring Device Product Portfolio
  • Table 107 : Medtronic: News/Key Developments, 2022-2024
  • Table 108 : Siemens Healthineers AG: Company Snapshot
  • Table 109 : Siemens Healthineers AG: Financial Performance, FY 2022 and 2023
  • Table 110 : Siemens Healthineers AG: Product Portfolio
  • Table 111 : Siemens Healthineers AG: News/Key Developments, 2022-2024
  • Table 112 : Smith & Nephew PLC: Company Snapshot
  • Table 113 : Smith & Nephew PLC: Financial Performance, FY 2022 and 2023
  • Table 114 : Smith & Nephew PLC: Product Portfolio
  • Table 115 : Smith & Nephew PLC: News/Key Developments, 2022-2024
  • Table 116 : Stryker: Company Snapshot
  • Table 117 : Stryker: Financial Performance, FY 2022 and 2023
  • Table 118 : Stryker: Product Portfolio
  • Table 119 : Stryker: News/Key Developments, 2022-2024
  • Table 120 : Sysmex Corp.: Company Snapshot
  • Table 121 : Sysmex Corp.: Financial Performance, FY 2022 and 2023
  • Table 122 : Sysmex Corp.: Product Portfolio
  • Table 123 : Sysmex Corp.: News/Key Developments, 2022-2024
  • Table 124 : Terumo Corp.: Company Snapshot
  • Table 125 : Terumo Corp.: Financial Performance, FY 2022 and 2023
  • Table 126 : Terumo Corp.: Product Portfolio
  • Table 127 : Terumo Corp.: News/Key Developments, 2022-2024
  • Table 128 : WuXi AppTec: Company Snapshot
  • Table 129 : WuXi AppTec Financial Performance, FY 2022 and 2023
  • Table 130 : WuXi AppTec: Product Portfolio
  • Table 131 : WuXi AppTec: News/Key Developments, 2022-2024
  • Table 132 : YPSOMED: Company Snapshot
  • Table 133 : YPSOMED: Financial Performance, FY 2022 and 2023
  • Table 134 : YPSOMED: Product Portfolio
  • Table 135 : YPSOMED: News/Key Developments, 2022-2024
  • Table 136 : Zeiss AG: Company Snapshot
  • Table 137 : Zeiss AG: Financial Performance, FY 2022 and 2023
  • Table 138 : Zeiss AG: Product Portfolio
  • Table 139 : Zeiss AG: News/Key Developments, 2022-2024
  • Table 140 : Zimmer Biomet: Company Snapshot
  • Table 141 : Zimmer Biomet: Financial Performance, FY 2022 and 2023
  • Table 142 : Zimmer Biomet: Product Portfolio
  • Table 143 : Zimmer Biomet: News/Key Developments, 2022-2024

List of Figures

  • Summary Figure : Global Market for Medical Devices, by Region, 2021-2029
  • Figure 1 : Supply Chain of the Medical Device Industry
  • Figure 2 : Market Dynamics of Medical Device Industry
  • Figure 3 : Marketing Process for Medical Devices in the U.S.
  • Figure 4 : Emerging Trends and Technologies in the Medical Device Industry
  • Figure 5 : ESG Metrics for Medical Device Companies
  • Figure 6 : Market Shares of Leading Medical Device Companies, 2023
  • Figure 7 : Abbott: Revenue Share, by Business Unit, FY 2023
  • Figure 8 : Abbott: Revenue Share, by Country/Region, FY 2023
  • Figure 9 : Alcon Inc.: Revenue Share, by Business Unit, FY 2023
  • Figure 10 : Alcon Inc.: Revenue Share, by Country/Region, FY 2023
  • Figure 11 : Align Technology Inc.: Revenue Share, by Business Unit, FY 2023
  • Figure 12 : Align Technology Inc.: Revenue Share, by Country/Region, FY 2023
  • Figure 13 : B. Braun SE: Revenue Share, by Business Unit, FY 2023
  • Figure 14 : B. Braun SE: Revenue Share, by Country/Region, FY 2023
  • Figure 15 : Baxter: Revenue Share, by Business Unit, FY 2023
  • Figure 16 : Baxter: Revenue Share, by Country/Region, FY 2023
  • Figure 17 : BD: Revenue Share, by Business Unit, FY 2023
  • Figure 18 : BD: Revenue Share, by Country/Region, FY 2023
  • Figure 19 : Bio-Rad Laboratories Inc.: Revenue Share, by Business Unit, FY 2023
  • Figure 20 : Bio-Rad Laboratories Inc.: Revenue Share, by Country/Region, FY 2023
  • Figure 21 : Boston Scientific Corp.: Revenue Share, by Business Unit, FY 2023
  • Figure 22 : Boston Scientific Corp.: Revenue Share, by Country/Region, FY 2023
  • Figure 23 : Bruker: Revenue Share, by Business Unit, FY 2023
  • Figure 24 : Bruker: Revenue Share, by Country/Region, FY 2023
  • Figure 25 : Cardinal Health: Revenue Share, by Business Unit, FY 2023
  • Figure 26 : Cardinal Health: Revenue Share, by Country/Region, FY 2023
  • Figure 27 : Cochlear Ltd.: Revenue Share, by Business Unit, FY 2023
  • Figure 28 : Cochlear Ltd.: Revenue Share, by Country/Region, FY 2023
  • Figure 29 : Danaher Corp.: Revenue Share, by Business Unit, FY 2023
  • Figure 30 : Danaher Corp.: Revenue Share, by Country/Region, FY 2023
  • Figure 31 : Dexcom Inc.: Revenue Share, by Sales Channel, FY 2023
  • Figure 32 : Dexcom Inc.: Revenue Share, by Country/Region, FY 2023
  • Figure 33 : Dentsply Sirona: Revenue Share, by Business Unit, FY 2023
  • Figure 34 : Dentsply Sirona: Revenue Share, by Country/Region, FY 2023
  • Figure 35 : Dragerwerk AG & Co. KGaA: Revenue Share, by Business Unit, FY 2023
  • Figure 36 : Dragerwerk AG & Co. KGaA: Revenue Share, by Country/Region, FY 2023
  • Figure 37 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Business Unit, FY 2023
  • Figure 38 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Country/Region, FY 2023
  • Figure 39 : GE HealthCare: Revenue Share, by Business Unit, FY 2023
  • Figure 40 : GE HealthCare: Revenue Share, by Country/Region, FY 2023
  • Figure 41 : Gerresheimer AG: Revenue Share, by Business Unit, FY 2023
  • Figure 42 : Gerresheimer AG: Revenue Share, by Country/Region, FY 2023
  • Figure 43 : Intuitive Surgical: Revenue Share, by Business Unit, FY 2023
  • Figure 44 : Intuitive Surgical: Revenue Share, by Country/Region, FY 2023
  • Figure 45 : Johnson & Johnson Services Inc.: Revenue Share, by Business Unit, FY 2023
  • Figure 46 : Johnson & Johnson Services Inc.: Revenue Share, by Country/Region, FY 2023
  • Figure 47 : Koninklijke Philips N.V.: Revenue Share, by Business Unit, FY 2023
  • Figure 48 : Koninklijke Philips N.V.: Revenue Share, by Country/Region, FY 2023
  • Figure 49 : LivaNova PLC.: Revenue Share, by Business Unit, FY 2023
  • Figure 50 : LivaNova PLC.: Revenue Share, by Country/Region, FY 2023
  • Figure 51 : Medtronic: Revenue Share, by Business Unit, FY 2023
  • Figure 52 : Medtronic: Revenue Share, by Country/Region, FY 2023
  • Figure 53 : Siemens Healthineers AG: Revenue Share, by Business Unit, FY 2023
  • Figure 54 : Siemens Healthineers AG: Revenue Share, by Country/Region, FY 2023
  • Figure 55 : Smith & Nephew PLC: Revenue Share, by Country/Region, FY 2023
  • Figure 56 : Smith & Nephew PLC: Revenue Share, by Business Unit, FY 2023
  • Figure 57 : Stryker: Revenue Share, by Business Unit, FY 2023
  • Figure 58 : Stryker: Revenue Share, by Country/Region, FY 2023
  • Figure 59 : Sysmex Corp.: Revenue Share, by Business Unit, FY 2023
  • Figure 60 : Sysmex Corp.: Revenue Share, by Country/Region, FY 2023
  • Figure 61 : Terumo Corp.: Revenue Share, by Country/Region, FY 2023
  • Figure 62 : Terumo Corp.: Revenue Share, by Business Unit, FY 2023
  • Figure 63 : WuXi AppTec: Revenue Share, by Business Unit, FY 2023
  • Figure 64 : WuXi AppTec: Revenue Share, by Country/Region, FY 2023
  • Figure 65 : YPSOMED: Revenue Share, by Business Unit, FY 2023
  • Figure 66 : YPSOMED: Revenue Share, by Country/Region, FY 2023
  • Figure 67 : Zeiss AG: Revenue Share, by Business Unit, FY 2023
  • Figure 68 : Zeiss AG: Revenue Share, by Country/Region, FY 2023
  • Figure 69 : Zimmer Biomet: Revenue Share, by Business Unit, FY 2023
  • Figure 70 : Zimmer Biomet: Revenue Share, by Country/Region, FY 2023